Talk:Innate Immunotherapeutics

This is the talk page for discussing improvements to the Innate Immunotherapeutics article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL

This article is rated Start-class on Wikipedia's content assessment scale.
It is of interest to the following WikiProjects:

Australia Low‑importance

	Australia portal Innate Immunotherapeutics is within the scope of WikiProject Australia, which aims to improve Wikipedia's coverage of Australia and Australia-related topics. If you would like to participate, visit the project page.AustraliaWikipedia:WikiProject AustraliaTemplate:WikiProject AustraliaAustralia articles
Low	This article has been rated as Low-importance on the project's importance scale.
	Need help improving this article? Ask a Librarian^{What's this?} at the National Library of Australia.
	The Wikimedia Australia chapter can be contacted via email to helpwikimedia.org.au for non-editorial assistance.

Companies Low‑importance

This article is within the scope of WikiProject Companies, a collaborative effort to improve the coverage of companies on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.CompaniesWikipedia:WikiProject CompaniesTemplate:WikiProject Companiescompany articles

Low This article has been rated as Low-importance on the project's importance scale.

WikiProject Companies To-do:

Here are some tasks awaiting attention:

Article requests : Wikipedia:Requested articles/Business and economics/Companies
Assess : Category:Unassessed company articles
Copyedit : Category:Company articles needing attention
Infobox : Category:Company articles needing infoboxes
Maintain : Portal:Companies
Stubs : Help expand stub articles located at Category:Company stubs
Other :
- Tag company articles with the {{portal|Companies}} template
- Tag company talk pages with the {{WikiProject Companies}} project banner
- Answer requests for comments

New Zealand Low‑importance

	New Zealand portal This article is within the scope of WikiProject New Zealand, a collaborative effort to improve the coverage of New Zealand and New Zealand-related topics on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.New ZealandWikipedia:WikiProject New ZealandTemplate:WikiProject New ZealandNew Zealand articles
Low	This article has been rated as Low-importance on the project's importance scale.

Article presumes guilt[edit]

The article states that Collins warned his son that the clinical trials had failed, citing [15] NY Times article. The conversation was not recorded, and at this point only those two know what was said. The NYT piece does not claim to know what was said, only reports the fact that the son sold off shares soon afterwards.

Sealed indictment[edit]

Can this "sealed indictment" be used as an RS?^[1] It is linked via document helper in the New York Times August 8, 2018 article.Oceanflynn (talk) 19:17, 8 August 2018 (UTC) ^[2][reply]

There are statements in the indictment that I have not found elsewhere yet. For example, "The public announcement of these results caused the stock price of Innate to drop by 92%."^[1] "In his capacity as a member of Innate’s Board of Directors, Collins regularly had access to material, nonpublic information, including about MIS416 and the Drug Trial."^[1] "In or about October 2014, Innate initiated a Phase 2B clinical trial of its primary drug, MIS416. The Drug Trial was “blinded,” meaning that neither the administrators of the Drug Trial nor Innate’s leadership would know or be able to determine the results of the Drug Trial until it was completed, after which point data collected during the course of the Drug Trial would be unblinded and analyzed. Successful completion of the Drug Trial was a necessary prerequisite to the commercialization of MI8416. Because Innate had no other significant products in development, its stock price was tied to the success of MIS416."^[1]

References

^ ^a ^b ^c ^d "Chris Collins Indictment" (PDF), New York Times, August 2018, retrieved August 8, 2018
^ Feuer, Alan; Goldmacher, Shane (August 8, 2018). "New York Congressman Chris Collins Is Charged With Insider Trading". The New York Times. Retrieved August 8, 2018.

That's a primary source, but a news outlet may cover it soon. Natureium (talk) 19:22, 8 August 2018 (UTC)[reply]

[INT_NYT_2018-1] "Chris Collins Indictment" (PDF), New York Times, August 2018, retrieved August 8, 2018

[NYT_Feuer_2018_II-2] Feuer, Alan; Goldmacher, Shane (August 8, 2018). "New York Congressman Chris Collins Is Charged With Insider Trading". The New York Times. Retrieved August 8, 2018.

[1]

[2]